Titre:
  • Front-line treatment of advanced non-small cell lung cancer with irinotecan and docetaxel: a multicentre phase II study.
Auteur:Ziotopoulos, Panagiotis; Androulakis, Nikolaos; Mylonaki, Efthimia; Chandrinos, Vassilios; Zachariadis, Emmanouel; Boukovinas, Ioannis; Agelidou, Athina; Kentepozidis, Nikolaos; Ignatiadis, Michail; Vossos, Andreas; Georgoulias, Vassilis; Lung Cancer Committee of the Hellenic Oncology Research Group (HORG),
Informations sur la publication:Lung cancer, 50, 1, page (115-122)
Statut de publication:Publié, 2005-10
Sujet CREF:Sciences bio-médicales et agricoles
Cancérologie
Médecine pathologie humaine
MeSH keywords:Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Camptothecin -- administration & dosage -- analogs & derivatives
Carcinoma, Non-Small-Cell Lung -- drug therapy -- pathology
Disease Progression
Female
Granulocyte Colony-Stimulating Factor -- administration & dosage
Humans
Infusions, Intravenous
Lung Neoplasms -- drug therapy -- pathology
Male
Middle Aged
Neutropenia -- chemically induced
Survival Analysis
Taxoids -- administration & dosage
Treatment Outcome
Langue:Anglais
Identificateurs:urn:issn:0169-5002
info:doi/10.1016/j.lungcan.2005.05.004
info:pii/S0169-5002(05)00243-6
info:pmid/15993981